Mahira
El Sayed
,
MSc, MD
Ain Shams University
Cairo
,
Egypt
Chair
IPC Board Member
CLOSING GAPS IN PSORIASIS CARE FOR DIVERSE SKIN TYPES
The Diverse Skin Tones Working Group is dedicated to addressing unmet needs in psoriasis care for diverse skin tones. The group focuses on enhancing dermatologists’ ability to diagnose and treat psoriasis in individuals with diverse skin accurately and collaborates with organizations, including patient and dermatology associations, to promote equitable care.
In 2025, the group achieved two significant milestones: publishing Psoriasis in People With Skin of Color: An Evidence-Based Update in the International Journal of Dermatology and launching Visual Differences in Psoriasis on Diverse Skin Tones, a clinical education tool aimed at improving diagnostic accuracy and advancing equitable care for patients with diverse skin tones.
Looking ahead, the Diverse Skin Tones Working Group will continue developing educational tools and resources for clinicians while fostering collaborations with organizations such as the GPA, IFPA, and the Skin of Color Society.
View more resources on diverse skin.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.